Intrinsiqq
ProMIS Neurosciences, Inc. logo

ProMIS Neurosciences, Inc. Insider Trading

PMN

Compare
Last 12 months

Insiders bought 377K on the open market and sold nothing.

Net open-market
+377K
8 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
4 / 0
executives and directors
Last open-market buy
Nov 2026
Nov 4, 2026

Get an email when PMN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 4
    Eugene Williams
    Director · bought 26,500 at $3.43
    91K
    193% of stake
  • Nov 2
    Neil Cashman
    Chief Scientific Officer · bought 10,000 at $3.86
    39K
    107% of stake
  • Oct 30
    Eugene Williams
    Director · bought 1,316 at $3.99
    5K
    11% of stake
  • Aug 5
    Johanne Kaplan
    Chief Development Officer · bought 2,280 at $13.30
    30K
    58% of stake
  • Apr 22
    Patrick D. Kirwin
    Director · bought 4,000 at $11.33
    45K
    66% of stake
  • Mar 5
    Eugene Williams
    Director · bought 2,000 at $24.40
    49K
    19% of stake
  • Mar 2 – 4
    Eugene Williams
    Director · bought 4,000 at avg $23.11
    92K
    63% of stake
  • Feb 19
    Johanne Kaplan
    Chief Development Officer · bought 1,629 at $15.35
    25K
    70% of stake
  • Feb 3
    Fan Yu
    Large holder · bought 700,741 at $12.13
    $8.5M
    289% of stake
  • Oct 3, 2025
    Max A. Milbury
    Other · bought 30,392 at $0.49
    15K
    203% of stake
  • Jun 30, 2025No plan
    Michael S Gordon
    Large holder · sold 93,223
    —
    4.2% of stake
  • Feb 10, 2025
    Neil Cashman
    Chief Scientific Officer · bought 15,000 at $0.97
    15K
    13% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PMN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with PMN

CompareIntrinsic value
SERSerina Therapeutics Inc.
$1.12-6.67%40
AZTRAzitra Inc.
$0.52-2.64%20
PLRXPliant Therapeutics Inc.
$0.60-4.02%10
LGVNLongeveron Inc.
$1.66-8.79%10
RCKTRocket Pharmaceuticals Inc.
$1.95-7.58%10
FULCFulcrum Therapeutics Inc.
$3.69-0.54%10
EVMNEvommune, Inc.
$7.04-2.76%35
RLMDRelmada Therapeutics Inc.
$2.62-15.76%10

Spot a number that looks wrong? Check it in PMN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing PMN

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.